MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC
NCT02592577
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-Small Cell Lung Cancer
Carcinoma
Interventions
BIOLOGICAL:
Autologous Genetically modified T cells, MAGEA10ᶜ⁷⁹⁶T
Sponsor
Adaptimmune